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OBJECTIVE — In health, the rise in glucose after lunch is less if breakfast is eaten. We
evaluated the second-meal effect in type 2 diabetes.
RESEARCH DESIGN AND METHODS — Metabolic changes after lunch in eight obese
type2diabeticsubjectswerecomparedon3days:breakfasteaten,nobreakfast,andnobreakfast
but intravenous arginine 1 h before lunch.
RESULTS — Despite comparable insulin levels, the rise in plasma glucose after lunch was
considerably less if breakfast had been eaten (0.68  1.49 vs. 12.32  1.73 vs. 7.88  1.03
mmol   h
1   l
1; P  0.0001). Arginine administration almost halved the lunch rise in plasma
glucose (12.32  1.73 vs. 7.88  1.03 mmol   h
1   l
1). The plasma free fatty acid concentra-
tion at lunchtime directly related to plasma glucose rise after lunch (r  0.67, P  0.0005).
CONCLUSIONS — The second-meal effect is preserved in type 2 diabetes. Premeal admin-
istrationofanonglucoseinsulinsecretagogueresultsinhalvingthepostprandialglucoseriseand
has therapeutic potential.
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T
he effect of a prior meal in decreas-
ing the rise in blood glucose after a
subsequent meal was ﬁrst recog-
nized almost a century ago (1). It has re-
peatedly been conﬁrmed in healthy
subjects, but tests with intravenous or
oral glucose suggested that the second-
meal effect does not occur in type 2 dia-
betes (2–4). We observed incidentally
that a second meal in subjects with type 2
diabetes brought about a 70% lesser rise
in blood glucose (5).
Thisstudywasdesignedtodetermine
whether the second-meal phenomenon is
present in type 2 diabetes and, if so,
whether this can artiﬁcially be induced as
a possible therapeutic approach.
RESEARCH DESIGN AND
METHODS— Eight subjects with
type 2 diabetes were recruited (aged
56.1  2.8 years, BMI 36.0  2.5 kg/m
2,
A1C 6.7  0.2%, diabetes duration
8.1  0.5 years, diet and/or metformin
treatment). Ethics committee permission
was obtained.
Study methods
The metabolic response to a standard
lunch was studied on 3 separate days in
random order with 2–4 weeks between
studies.OndayA,thesubjectshadastan-
dard breakfast followed by the standard
lunch. On day B, breakfast was omitted.
On day C, breakfast was omitted and ar-
ginine was infused 1 h before lunch. The
details of metabolic testing, arginine ad-
ministration, and hormone and metabo-
lites assays were as previously described
(5,6).
Meal composition
The standard breakfast consisted of 50 g
muesli, 100 g milk, two slices of toast (56
g), 20 g marmalade, 20 g margarine, and
200 ml orange juice (106 g carbohydrate,
18gfat,15gprotein,646kcal).Thestan-
dardlunchcomprisedacheesesandwich,
200 ml orange juice, 170 g yogurt, and
150 g jelly (103 g carbohydrate, 30 g fat,
44 g protein, 858 kcal).
Statistical analysis
Data are presented as means  SE. One-
way ANOVA and linear correlation were
performed using MINITAB (State Col-
lege, PA).
RESULTS
Glucose
The rise in plasma glucose after lunch
was greatest on the day without break-
fast and almost 40% lower on the argi-
nine day (0.68  1.49 vs. 12.32  1.73
vs. 7.88  1.03 mmol   h
1   l
1; P 
0.0001) (Fig. 1A).
On day A, breakfast increased plasma
glucose from 7.6  0.4 to 13.3  1.0
mmol/lat2hand8.40.7mmol/lat4h.
On day B (no breakfast), plasma glucose
fellfrom8.00.4to6.50.3mmol/lby
4 h. Two hours after the test, lunch
plasma glucose was 8.6  0.6 mmol/l on
day A compared with 10.9  0.8 mmol/l
on day B.
On day C, fasting plasma glucose fell
from 7.6  0.6 mmol/l to 6.6  0.6
mmol/l at 3 h just before the arginine in-
fusion and was 7.1  0.7 mmol/l at 4 h.
Serum insulin and C-peptide
Fasting serum insulin was similar on each
of the days (127  23, 140  48, and
115  27 pmol/l for days A, B, and C,
respectively; P  0.87). The post-lunch
serum insulin concentrations were com-
parable on days A, B, and C (1,918  45
vs. 2,040 75 vs. 1,472 40 pmol  h
1 
l
1, respectively; P  0.76). On day A,
serum insulin peaked at 954  237
pmol/l 2 h after breakfast. On day C, in-
sulin concentrations increased sharply af-
ter30minofthearginineinfusion(418
177 pmol/l) but returned to the baseline
(157  37 pmol/l) before lunch.
Insulin–to–C-peptide ratios were
similar after the test lunch on all three
experimental days (144  23, 185  47,
and 168  31 pmol/nmol, respectively;
P  0.73 at 2 h after lunch).
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Fasting glucagon levels were similar on
eachofthethreeexperimentaldays(87
11, 83  9, and 83  7 pg/ml, respec-
tively). On day C, the arginine infusion
induced a threefold increase in glucagon
concentrations after 30 min to a short-
lived peak of 263  28 pg/ml.
Pre-lunch and 30-min post-lunch
adrenalinelevelsweresimilaroneachday
(0.32  0.06, 0.36  0.04, and 0.37 
0.04 nmol/l; P  0.77; and 0.34  0.04,
0.41  0.06, and 0.39  0.04 nmol/l,
respectively; P  0.67).
Plasma free fatty acids
Fasting plasma free fatty acids (FFAs)
were similar on the three study days
(0.640.07,0.650.9,and0.670.7
mmol/l, respectively; P  0.96). After
breakfast on day A, plasma FFA levels
were suppressed within2ht o0.18 
0.04mmol/l.OndayB,plasmaFFAswere
0.65  0.4 mmol/l before and 0.27 
0.04 mmol/l 2 h after lunch. On day C,
plasma FFAs were suppressed by the ar-
ginineinfusion(0.350.04mmol/l)and
the lunch (0.18  0.03 mmol/l 2 h after
lunch).TheconcentrationofplasmaFFAs
was strongly related to the area under the
curveoftheplasmaglucoseconcentration
after lunch (r  0.67, P  0.0005) (Fig.
1B).
CONCLUSIONS— In obese type 2
diabetic subjects, the rise in plasma glu-
cose was 95% less after lunch when the
lunch had been preceded by breakfast,
conﬁrming the occurrence of the second-
meal effect in type 2 diabetes. The effect
on plasma glucose was similar or slightly
greater than that in healthy subjects (73%
decrease in post-lunch hyperglycemia)
(7). Substrate oxidation rates were un-
changed across experimental days (data
not shown). The plasma FFA concentra-
tion before lunch correlated positively
withthepost-lunchriseinplasmaglucose
after lunch. The post-lunch insulin pro-
ﬁles were similar on all test days.
The concept that the second-meal
phenomenon did not occur in type 2 di-
abetes is derived from study of repeated
intravenousglucose(3),althoughthishas
a poor effect on insulin secretion (8). In
contrast, a mixed meal or injection of
amino acids brings about an increase in
plasma insulin levels, even in type 2 dia-
betes (8,9).
The second-meal phenomenon is not
mediated by an acute effect on insulin se-
cretion, and FFA suppression must be
considered. Increased FFA induces insu-
lin resistance in humans (10,11). Con-
versely, suppression of plasma FFA by
acipimox acutely improves insulin action
in type 2 diabetes by increasing glucose
storage as muscle glycogen and decreas-
inghepaticglucoseproduction(9,12,13).
An increase in FFAs leads to an inhibition
of net hepatic glycogen breakdown and
increases gluconeogenesis (14). We re-
cently observed that, in normal subjects,
the second-meal phenomenon was asso-
ciated with increased rates of storage of
lunchtime carbohydrate in muscle glyco-
gen (7).
The present data demonstrate that
under everyday conditions, postprandial
glucose metabolism in type 2 diabetes is
facilitated by suppression of plasma FFA
concentrations after a previous meal.
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